ALBANY, N.Y., Sept. 14, 2017 -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2018 first quarter ended August 31, 2017, on Thursday, September 28, 2017, before the open of the U.S. financial markets.
Management will host a conference call and webcast beginning at 8:00am E.T. on September 28 to discuss the results from the fiscal 2018 first quarter and answer questions. To participate in the live call by telephone, please call 800-263-8506 and reference the Conference ID: 9276207.
A live webcast and subsequent archived replay of the conference call may be accessed via the investor relations section of the Company's website under "Events & Presentations" at investors.angiodynamics.com/events. To listen to the live webcast, please go to the website 15-minutes prior to its start to register, download and install the necessary audio software.
About AngioDynamics
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products. More information is available at AngioDynamics.com.
Trademarks
AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
Contact:
Caitlin Stefanik
(518) 795-1418
[email protected]


Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
First Western Ship Transits Strait of Hormuz Since Iran War Began
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
UPS and Teamsters Reach Agreement to Limit Driver Severance Program 



